糖尿病正成为越来越严重的公共健康问题,全球糖尿病患者总数已超过5亿。I型和重症II型糖尿病的治疗离不开胰岛素,精准控制胰岛素的给药剂量对患者的治疗至关重要。剂量过低起不到理想的治疗效果,过高将导致低血糖,可能危及患者生命,其中以夜间低血糖最为致命,约占糖尿病总致死人数的6%。目前主要采用分次注射胰岛素的方法改善夜间低血糖问题,但是该方法需要人工调节注射的胰岛素剂量,操作较为麻烦。因此,设计具有葡萄糖响应性能的胰岛素递送体系,根据血糖浓度实时自适应地控制胰岛素的释放对夜间血糖控制具有重要意义。
近日,浙江大学王立教授和俞豪杰副教授团队受脂肪酸/白蛋白疏水相互作用的启发,基于分子对接技术设计了一种脂肪酸与苯硼酸衍生物双修饰的纳米粒子用于胰岛素负载与血糖浓度响应释放,其设计思路如Figure 1所示。通过分子对接技术将脂肪酸基团片段与胰岛素的相互作用域可视化,并结合数据分析发现随脂肪酸基团链长增长,其与胰岛素间的疏水作用变强(Figure 2),这有利于抑制胰岛素的突释行为,从而避免胰岛素释放过快导致的低血糖症状。
Figure 2. The affinities of MACns to INS and the corresponding simulated images. The images included structure information from RCSB PDB (ID: 4INS) and the simulation results from Autodock Vina and were presented via PyMOL.
通过实验验证了正丁酸、正己酸、正辛酸、正癸酸和月桂酸对纳米粒子自组装行为的影响,发现脂肪酸基团链长适中时,纳米粒子自组装形貌更规整,有利于胰岛素的负载(Figure 3)。制备了9种脂肪酸与苯硼酸衍生物双修饰纳米粒子并筛选出性能最优的纳米粒子C10MS,其胰岛素负载量为0.17 g胰岛素/g载体。C10MS能抑制胰岛素的突释行为,表现出稳定的糖敏胰岛素释放性能。
Figure 3. SEM images of (a) C4MS, (b) C6MS, (c) C8MS, (d) C10MS and (e) C12MS and the schematic diagrams (bar = 500 nm).
Figure 4. The glucose-responsive insulin-releasing mechanism.
Figure 5. (a, b) The hypoglycemia-avoiding performances of the anti-diabetes agents evaluated on healthy rats with (c) the statistical analysis. (d, e) The 8-h hyperglycemia-ameliorating and hypoglycemia-avoiding performances of the anti-diabetes agents evaluated on diabetic rats with (f) the statistical analysis. (g) The 14-h hyperglycemia-ameliorating and hypoglycemia-avoiding performances. The data of “Diabetic control” were shown as the means ± SD (n = 3). The data of “Healthy control”, “C6MS”, “C8MS”, “C10MS”, “INS”, “Det-INS”, “INS(H) + Det-INS(L)” and “INS(L) + Det-INS(H)” were shown as the means ± SD (n = 5). The statistical analyses were performed by two-tailed Student''s t-test. * P < 0.05 and ** P < 0.01.
Figure 6. (a) The MTT assays and live-dead cell staining assays for CnMSs (n = 6, 8 and 10, scale bar = 200 μm). (b) The hemolysis tests for CnMS (n = 4, 6, 8, 10 and 12) and the routine blood test for C10MS. (c) The in vivo fluorescence test on diabetic rats by using Cy5-labeled C10MS. (d) Histological analyses of C10MS on hearts, livers, spleens, lungs, and kidneys (scale bar = 100 μm). The data of MTT assays were shown as the means ± SD (n = 6). The data of hemolysis tests were shown as the means ± SD (n = 3). The data of the routine blood test were shown as the means ± SD (n = 4).
论文链接:https://doi.org/10.1016/j.jconrel.2022.10.044
- 弗吉尼亚理工大学刘国良课题组许振博士 Science:聚乙烯和聚丙烯向脂肪酸转化的高价值化学升级回收 2023-08-18
- 朱剑波教授团队 Nature Catalysis:基于螺环Salen-钇催化剂化学合成立构规整性聚羟基脂肪酸酯 2023-08-15
- 浙大宁理刘宏治教授、郑大刘浩副教授合作《Macromolecules》:二官能度脂肪酸单体动态硫化增韧聚乳酸 2022-11-20
- 兰州大学卜伟锋/兰州化物所蔡美荣、周峰/西南科大常冠军 Macromolecules:动态共价聚合物-纳米粒子复合油凝胶润滑剂 2024-08-25
- 四川大学李建树教授/杨佼佼副研究员 Small:用于清除胞内菌感染的级联靶向纳米系统 2024-05-08
- 华南理工殷盼超教授 JPCL:颗粒基软结构材料的设计与构效关系研究 2024-04-28
- 浙江大学王立教授、俞豪杰教授团队 Carbohyd. Polym.:基于糖敏水凝胶的智能长效胰岛素递送微针贴 2024-11-21